Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Lack of cystatin M/E causes thin hair and dry skin.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Vitamin D is crucial for skin health and managing skin diseases.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

A boy with progeria had eye problems and signs of aging like hair loss and skin wrinkling.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.